Lisa DeAngelis, MD, Neurology, New York, NY, Memorial Sloan-Kettering Cancer Center

LisaMDeAngelisMD

Neurology New York, NY

Neurooncology

"Co-Executive Director of the Brain Tumor Center at Memorial Sloan Kettering Chair, Department of Neurology; Lillian Rojtman Berkman Chair in Honor of Jerome B. Posner"

Overview of Dr. DeAngelis

Dr. Lisa DeAngelis is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and NYC Health + Hospitals / Bellevue. She received her medical degree from Columbia University College of Physicians & Surgeons and has been in practice 37 years. She is one of 47 doctors at Memorial Sloan-Kettering Cancer Center and one of 42 doctors at NYC Health + Hospitals / Bellevue who specialize in Neurology.

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterResidency, Neurology, 1985 - 1986
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusResidency, Neurology, 1983 - 1985
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusInternship, Internal Medicine, 1980 - 1981
  • Columbia University College of Physicians & Surgeons
    Columbia University College of Physicians & SurgeonsClass of 1980

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • NY State Medical License
    NY State Medical License 1981 - 2023
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Marked Response of a Hypermutated Adrenocorticotropic Hormone-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab  
    Michael Postow, Viviane Tabar, T Jonathan Yang, John Cuaron, Jinru Shia, Lisa M DeAngelis, The Journal of Clinical Endocrinology and Metabolism
  • Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal Lymphoma  
    Lisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood

Lectures

  • Reevaluation of the Frequent Use of PD-1 Checkpoint Inhibitors for Treatment of Glioblastoma 
    American Academy of Neurology (AAN), San Diego, California - 3/16/2013

Authored Content

  • Reevaluation of the Frequent Use of PD-1 Checkpoint Inhibitors for Treatment of GlioblastomaMay 2020

Press Mentions

  • Ingo Mellinghoff Named Chair of MSK's Department of Neurology
    Ingo Mellinghoff Named Chair of MSK's Department of NeurologyOctober 28th, 2020
  • E-cig, Medical-Marijuana Sellers Closely Watch NY's Anti-Vaping Actions
    E-cig, Medical-Marijuana Sellers Closely Watch NY's Anti-Vaping ActionsSeptember 11th, 2019
  • MSK to Open Nassau Outpatient Cancer Center
    MSK to Open Nassau Outpatient Cancer CenterApril 3rd, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations